Medial thalamotomy [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.
====== Medial thalamotomy ======

First introduced in the 1950s, [[thalamotomy]] is an invasive procedure, primarily effective for [[tremor]]s such as those associated with [[Parkinson's disease]] (PD), where a selected portion of the [[thalamus]] is surgically destroyed (ablated). 

The proton density MRI was demonstrated to be very useful to determine the safest trajectory and tentative target point. However, as a detailed functional localization of the thalamic subnuclei cannot be yet obtained by MRI, the final target should be decided on the basis of electrophysiological findings
((Kawashima Y, Chen HJ, Takahashi A, Hirato M, Ohye C. Application of magnetic
resonance imaging in functional stereotactic thalamotomy for the evaluation of
individual variations of the thalamus. Stereotact Funct Neurosurg.
1992;58(1-4):33-8. PubMed PMID: 1439346.
)).

Bilateral procedures are poorly tolerated because of increased complication and risk, including vision and speech problems. The positive effects on tremors are immediate. Other less destructive procedures are sometimes preferred, such as [[subthalamic deep brain stimulation]] (DBS), since this procedure can also improve tremors and other symptoms of PD.

===== Classification =====

[[Radiofrequency Thalamotomy]]

[[Gamma Knife thalamotomy]].

[[Magnetic resonance guided focused ultrasound thalamotomy]].

[[Stereotactic robot-assisted MRI-guided laser interstitial thermal therapy thalamotomy]]

===== Outcome =====

[[Thalamotomy outcome]].

----

69 patients suffering from chronic therapy-resistant neurogenic pain of peripheral and/or central origin underwent a stereotactic medial [[thalamotomy]]. Medial thalamic unit recordings were performed peroperatively, allowing the physiological confirmation of the electrode location and the recognition of a specific physiopathology. Thanks to these recordings, a concept was developed, based on the presence of an imbalance between medial (nucleus centralis lateralis mainly) and lateral (nucleus ventroposterior) thalamic nuclei, resulting in an over-inhibition of both by the reticular thalamic nucleus, and then in a paradoxical activation of pain-related cortical areas. The medial thalamotomy, re-actualized by new technical, anatomical and physiological data, offers a 50-100% relief to 67% of all patients with peripheral as well as central neurogenic pain, on all body localizations, without producing neurological deficits and without risk for the development of iatrogenic pain
((Jeanmonod D, Magnin M, Morel A. Chronic neurogenic pain and the medial thalamotomy. Schweiz Rundsch Med Prax. 1994 Jun 7;83(23):702-7. PMID: 8016511.)).